Cancer completely disappeared from two-thirds of 24 patients treated with a combination of the antibody petosemtamab and ...

Gardiner Harris’s investigation of Johnson & Johnson explores the many ways corporate greed and weak regulations fail to ...

Not only are pharmaceutical stocks excellent defensive investments, some pharma stocks pay sizable dividends that can be a ...

Health care giant Johnson ... drug Risperdal to the company’s role in the nation’s opioid crisis. But Harris doesn’t spare others from scrutiny or criticism with his book. Namely, he focuses on what ...

Johnson & Johnson stock slipped Tuesday, even after the company reported first-quarter earnings that surpassed expectations ...

The move would trigger an overhaul of scores of products on U.S. grocery store shelves. The plan was announced Tuesday ...

Healthcare and medical technology company Johnson & Johnson (JNJ) has reported first-quarter financial results that beat Wall ...

Health system pharmacists and physicians are monitoring a wave of expected new drug approvals between late 2024 and third quarter of 2025. A recent article published in the American Journal of ...

For medical-technology and pharmaceuticals manufacturing, “the most effective answer is not tariffs but tax policy,” Johnson ...

Miami-based Fruselva issued the recall in March for Target’s Good & Gather Baby Pea, Zucchini, Kale & Thyme Vegetable Puree, ...

At the American Urological Association (AUA) that starts later this week, J&J is scheduled to report that TAR-200 achieved a ...

Reese Marketos played the role of government prosecutor in a False Claims Act case about alleged off-label use of an HIV drug ...